Physician profile
Sandra Indacochea Sobel
NPI 1851550891
$175,926.58
in general payments reported to CMS, 2019-2025
12 companies · $87K in 2025
The $87K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2021: $179 · 2022: $7,758 · 2023: $37K · 2024: $44K · 2025: $87K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $129K · Consulting Fee: $19K · Travel and Lodging: $17K · Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $129,150.99 |
| Consulting Fee | $18,750.00 |
| Travel and Lodging | $16,877.69 |
| Food and Beverage | $2,963.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $109,303.81 | 2022-2025 | Wegovy |
| Lilly USA, LLC | $55,316.81 | 2025 | Zepbound |
| Sanofi-Aventis U.S. LLC | $8,249.14 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,153.00 | 2025 | |
| Cequr Corporation | $412.50 | 2022 | |
| Dexcom, INC. | $135.24 | 2021 | |
| Insulet Corporation | $86.46 | 2019 | |
| Tandem Diabetes Care, INC. | $72.56 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Becton, Dickinson and Company | $70.99 | 2019 | |
| Mannkind Corporation | $59.40 | 2022 | |
| Abbvie INC. | $41.94 | 2023-2024 | Ubrelvy |
| Abbott Laboratories | $24.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.